<DOC>
<DOCNO>EP-0641200</DOCNO> 
<TEXT>
<INVENTION-TITLE>
2-ARYLPROPIONIC ACID COMPOSITIONS AND PROCESS FOR PREPARING THE SAME
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K4724	A61K4724	A61K920	A61P2900	A61K4702	A61K3119	A61K920	A61P2900	A61K4702	A61K31185	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61P	A61K	A61K	A61K	A61P	A61K	A61K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K47	A61K47	A61K9	A61P29	A61K47	A61K31	A61K9	A61P29	A61K47	A61K31	</CLASSIFICATIONS-FOURTH>
<APPLICANTS>
<APPLICANT-NAME>
PAZ ARZNEIMITTELENTWICKLUNG
</APPLICANT-NAME>
<APPLICANT-NAME>
PAZ ARZNEIMITTEL- ENTWICKLUNGSGESELLSCHAFT MBH
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
BAUER KURT
</INVENTOR-NAME>
<INVENTOR-NAME>
BRUNE KAY
</INVENTOR-NAME>
<INVENTOR-NAME>
GEISSLINGER GERD
</INVENTOR-NAME>
<INVENTOR-NAME>
HUBER ANTON S
</INVENTOR-NAME>
<INVENTOR-NAME>
BAUER, KURT
</INVENTOR-NAME>
<INVENTOR-NAME>
BRUNE, KAY
</INVENTOR-NAME>
<INVENTOR-NAME>
GEISSLINGER, GERD
</INVENTOR-NAME>
<INVENTOR-NAME>
HUBER, ANTON, S.
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Process for the production of compositions of 2-arylpropionic
acid derivatives with improved tablettability

which contain per se known adjuvant and/or
carrier materials, characterised in that the arylpropionic

acid is mixed in the dry state with a calcium
compound and, after addition of the remaining adjuvant

and/or carrier materials, pressed directly to tablets.
Process according to claim 1, characterised in that
a pharmaceutically compatible wetting agent is used

as adjuvant material.
Process according to claim 1 or 2, characterised
in that ibuprofen racemate or S-ibuprofen is used as

arylpropionic acid derivative.
Process according to claim 1, 2 or 3, characterised

in that CaHPO
4
 or CaCO
3
 is contained as
calcium compound.
Pharmaceutical composition according to one of
claims 1 to 4.
</CLAIMS>
</TEXT>
</DOC>
